Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Redução de Energia e Umami (Season)

6 de novembro de 2026 atualizado por: Ciaran Forde, Wageningen University

Efeitos Interativos da Intensidade do Sabor Umami e da Densidade Energética na Ingestão Alimentar a Longo Prazo

People tend to regulate intake by the weight of food rather than its energy content, making energy dense foods, especially those combining salty, fatty, and umami tastes, more likely to promote passive overconsumption. Lowering energy density can reduce daily energy intake, but often decreases palatability, whereas umami can enhance palatability, and sometimes decrease food intake. This suggests that adding umami to a regular energy dense diet could reduce food intake over time, and that adding umami to a reduced energy dense diet could sustain palatability and limit compensatory energy intake. Therefore, the aim of this study is to assess the effect of a 2-week dietary intervention of adding umami and/or lowering energy density on food intake. Secondary objectives are whether adding umami and/or lowering energy density affect dietary satisfaction, appetite, perceived umami intensity, food preferences, bodyweight and composition, and wellbeing ratings.

This will assessed in a double-blind crossover, randomized controlled trial of three times two weeks, each separated by two weeks washout in 33 healthy Dutch adults between 18-65 years of age, with a BMI between 20-30. Umami taste will be added through MSG supplementation of the three main meals. Supplementation will depend on both intervention group, and individual participants' body weight. Energy density will be lowered by swapping regular products for low-fat, low-sugar or higher water products.

The three intervention diets will vary in umami taste intensity, and/or energy density: 1) regular energy density without added umami (control), 2) regular energy density with added umami, 3) reduced energy density with added umami. Umami will be supplemented by supplementing food items with 55-60 mg MSG per kg bodyweight daily, divided over three eating occasions. Foods will be offered ad libitum, and participants will add a seasoning sachet containing MSG to their selected portion.

The primary objective will be to compare average daily food intake (kcal) over two weeks between the three dietary interventions differing in umami taste intensity and energy density. Secondary outcomes are dietary satisfaction, appetite, perceived umami intensity, food preferences, bodyweight and composition, and wellbeing ratings.

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Estimado)

30

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

    • Gelderland
      • Wageningen, Gelderland, Holanda, 6708WE
        • Recrutamento
        • Department of Human Nutrition, Wageningen University
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 65 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Healthy: as judged by the participant;
  • Age 16-65 years at the time of inclusion, assessed by date of birth;
  • Proper understanding of the Dutch language, as questionnaires will be in Dutch;
  • Able to visit Wageningen University, as required for dietary intervention and testing;
  • Body mass index 20-30 kg/m2;
  • Having normal taste ability, assessed using Mueller taste strip test, ≥12 out of 20 assessed correctly.

Exclusion Criteria:

  • Suffering from endocrine- or gastro-intestinal diseases or other diseases that might influence study outcomes (such as diabetes, Crohn's disease, cardiovascular disease, hypertension, etc.);
  • Diagnosed with eating disorders (currently or in the past);
  • Diagnosed with taste or smell disorders in the past six months;
  • Pregnant or lactating during the study intervention;
  • Following a strict dietary regime;
  • Extreme physical activity (>10 hours per week moderate/high intensity exercise);
  • Gain or loss of more than 5 kgs in the last six months prior to study entry;
  • Suffering from lack of appetite for any reason;
  • Use of medication that may influence the appetite (medication will be judged by the medical investigator);
  • Having a food allergy and/or intolerance for foods used in the dietary intervention (e.g. lactose intolerance, gluten intolerance, MSG sensitivity). This will be assessed with an open question;
  • Consumes more than 14 (women) or 21 (men) glasses of alcohol per week;
  • Consumes MSG-rich sauces (soy sauce, ketjap and/or curry paste) more than once per day, or consumes more than 3 savoury food items (paprika chips, instant noodles, sundried tomatoes and/or pre-packaged seasonings) per day. This will be assessed with a frequency of consumption table;
  • Irregular eating pattern. This will be measured with a frequency of meal/food consumption table, and is defined as: frequency of breakfast consumption less than once per week;
  • Unwilling to maintain regular exercise pattern during the study period. This will be assessed with a yes/no question;
  • Unwilling to quit use of soft or hard drugs during the intervention;
  • Student or personnel of the division of Human Nutrition and Health, Wageningen University;
  • Participating in any other intervention study/studies or planning to participate in another intervention study during the study period.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Ciência básica
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição cruzada
  • Mascaramento: Triplo

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: regED/-MSG -> regED/+MSG -> lowED/+MSG

Participants receive Intervention regED/+MSG in Period 1, Intervention regED/-MSG in Period 2, and Intervention lowED/+MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Outros nomes:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Outros nomes:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Outros nomes:
  • lowED/+MSG
Experimental: regED/-MSG -> lowED/-MSG -> regED/+MSG

Participants receive Intervention regED/-MSG in Period 1, Intervention lowED/+MSG in Period 2, and Intervention regED/+MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Outros nomes:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Outros nomes:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Outros nomes:
  • lowED/+MSG
Experimental: regED/+MSG -> lowED/+MSG -> regED/-MSG

Participants receive Intervention regED/+MSG in Period 1, Intervention lowED/+MSG in Period 2, and Intervention regED/-MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Outros nomes:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Outros nomes:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Outros nomes:
  • lowED/+MSG
Experimental: regED/+MSG -> regED/-MSG -> lowED/+MSG

Participants receive Intervention regED/+MSG in Period 1, Intervention regED/-MSG in Period 2, and Intervention lowED/+MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Outros nomes:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Outros nomes:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Outros nomes:
  • lowED/+MSG
Experimental: lowED/+MSG -> regED/+MSG -> regED/-MSG

Participants receive Intervention lowED/+MSG in Period 1, Intervention regED/+MSG in Period 2, and Intervention regED/-MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Outros nomes:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Outros nomes:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Outros nomes:
  • lowED/+MSG
Experimental: lowED/+MSG -> regED/-MSG -> regED/+MSG

Participants receive Intervention lowED/+MSG in Period 1, Intervention regED/-MSG in Period 2, and Intervention regED/+MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Outros nomes:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Outros nomes:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Outros nomes:
  • lowED/+MSG

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Food intake (kcal)
Prazo: From start to end of each intervention (day 1-14, day 29-42 and day 57-72).

Difference between interventions in daily food intake, averaged over two weeks. Food intake is defined as total daily energy intake from meal, snack and drink consumption. Food intake will be measured by weighing breakfast, lunch and dinner intake in grams, which will be converted to energy (kcal). Snack and drink consumption will be recorded and converted to energy (kcal) as well. Food intake is measured daily, and averaged over each intervention.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72).

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Dietary satisfaction
Prazo: Measured at day 14 (end) of each intervention.

Difference in dietary satisfaction scores between interventions, measured with the dietary satisfaction questionnaire (DSat-45). Difference between dietary satisfaction scores will be compared between the three interventions.

Measured at day 14 (end) of each intervention.
Appetite and thirst ratings
Prazo: From start to end of each intervention (day 1 to day 14, day 19 to day 42 and day 56 to day 70).

Appetite and thirst ratings will be measured six times daily (before three main meals and at three random times each day). Difference between average appetite and thirst ratings will be compared between the three interventions.

From start to end of each intervention (day 1 to day 14, day 19 to day 42 and day 56 to day 70).
Taste Preference
Prazo: Measured at day 14 (end) of each intervention.

Preference for sweet/fa, sweet, salt/fat and salt tastes will be measured using PrefQuest at the end of each intervention (day 14). Differences of preferences for these tastes will be compared between the three interventions.

Measured at day 14 (end) of each intervention.
Perceived umami taste intensity
Prazo: Measured at day 14 (end) of each intervention.

Perceived umami taste intensity will be measured at the end of each intervention during a sensory test, during which participants will rate their perceived umami taste intensity of samples differing in food type (solid, semi-solid, liquid) and MSG concentration. Differences in perceived umami taste intensity will be compared between the three interventions.

Measured at day 14 (end) of each intervention.
Fat mass
Prazo: Six times during each intervention (day 1, 3, 6, 8, 12 and 14).

Changes in fat mass will be measured using Bioelectrical Impedance Analysis (BIA), and compared between the three interventions.

Six times during each intervention (day 1, 3, 6, 8, 12 and 14).
Bodyweight
Prazo: Six times during each intervention (day 1, 3, 6, 8, 12 and 14).

Changes in bodyweight will be measured using a calibrated scale, and compared between the three interventions.

Six times during each intervention (day 1, 3, 6, 8, 12 and 14).
Differences in MSG complex syndrome related complaints
Prazo: From start to end of each intervention (day 1-14, day 29-42 and day 57-72)

MSG syndrome complex related complaints will be assessed daily using an MSG tolerance questionnaire. Number of reported complaints in differences of MSG complex syndrome related complaints will be compared between the three interventions.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72)
Difference in adverse events or medication use
Prazo: From start to end of each intervention (day 1-14, day 29-42 and day 57-72)

The difference in Adverse events occurence, or medication use between intervention groups at the end of each intervention, adjusted for baseline differences. This will be measured daily by a questionnaire.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72)
Difference between change in food intake over time
Prazo: From start to end of each intervention (day 1-14, day 29-42 and day 57-72).

Difference between interventions in the day-to-day pattern of food intake across the two-week intervention periods. Food intake is defined as total daily energy intake from meal, snack and drink consumption. Food intake will be measured by weighing breakfast, lunch and dinner intake in grams, which will be converted to energy (kcal). Snack and drink consumption will be recorded and converted to energy (kcal) as well. Food intake is measured daily, and averaged over each intervention.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72).

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
MSG consumption
Prazo: From start to end of each intervention (day 1-14, day 29-42 and day 57-72)

MSG will be administered based on intervention group and bodyweight of each individual participant. Daily MSG consumption will be measured by asking participants to return empty sachets that contained the MSG supplementation. Differences in MSG consumption between the interventions will be reported as a compliance measure.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72)
Sex
Prazo: Baseline (day 0)

Based on self-report in the screening questionnaire. Baseline characteristic.

Baseline (day 0)
Age
Prazo: Baseline (day 0)

Based on self-report in the screening questionnaire. Baseline characteristic.

Baseline (day 0)
Height
Prazo: Baseline (day 0)

Will be assessed using a stadiometer as the average of two measurements, rounded to the closest decimal. This will be done during the physical screening session.

Baseline (day 0)
Baseline medicine usage
Prazo: Baseline (day 0)

Based on self-report in the screening questionnaire. Baseline characteristic.

Baseline (day 0)
Smoking status
Prazo: Baseline (day 0)

Based on self-report in the screening questionnaire. Baseline characteristic.

Baseline (day 0)
Dietary restraint score
Prazo: Baseline (day 0)

Measured by the Dutch Eating Behaviour Questionnaire (DEBQ).

Baseline (day 0)
Dietary taste patterns
Prazo: Baseline (day 0)

Measured by Food Frequency Questionnaire designed to classify people on taste consumption patterns (tasteFFQ). Results will be used to describe habitual food intake based on taste (relative food intake in grams of each taste) at baseline.

Baseline (day 0)
Physical activity level
Prazo: Measured at day 14 (end) of each intervention.

Measured using the SQUASH questionnaire with a reference period of two weeks. This is a compliance measure as participants are asked to maintain stable exercise patterns during the study period. Physical activity will be reported as a along with descriptive measures of participant characteristics.

Measured at day 14 (end) of each intervention.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Colaboradores

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

11 de fevereiro de 2027

Conclusão Primária (Estimado)

1 de abril de 2027

Conclusão do estudo (Estimado)

1 de abril de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

20 de fevereiro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

20 de fevereiro de 2026

Primeira postagem (Real)

27 de fevereiro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

12 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

6 de novembro de 2026

Última verificação

1 de fevereiro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • NL-011508

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

Individual participant data that underline the results reported in an article after de-identification will be shared.

Prazo de Compartilhamento de IPD

Following the publication. No end date.

Critérios de acesso de compartilhamento IPD

Anyone who whishes to access the data for secondary analysis must contact corresponding authors of specific publications for their approval. Next to this, they must reference the source of the data to provide appropriate credit to those who generated the data and allow searching for the studies it has supported.

Tipo de informação de suporte de compartilhamento de IPD

  • SEIVA
  • ANALYTIC_CODE

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever